lonza,原代细胞和干细胞,Liver-Derived Endothelial Cells, human, passage 2
2022年3月27日Product Overview
Endothelial cells are the primary barrier cells that line blood vessels and sinusoids of the liver. Human Liver-derived Endothelial Cells (HLECs) are isolated and enriched from liver tissue, then cryopreserved for use in a wide range of research models.
HLECs are characterized for markers of endothelial cells, including CD31, vWF, and LYVE-1 as shown by flow cytometry and maintain appropriate endothelial morphology over limited serial passaging. Human liver-derived endothelial cells are derived from whole livers leading to a mixed population of vascular endothelial cells and sinusoidal endothelial cells.
The recommended medium for HLECs is EGMTM 2 which is optimized for endothelial cell health and growth.
Benefits
Low passage
Applications
- ADMETox
- Liver Disease
- NASH
Content & Storage
Content
Cryo Vial >800,000 cells
Instructions
Safety Data Sheets (SDS)
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
The importance of cell-subtype selection in creation of a 3D liver fibrosis model
Data sheet detailing 3D liver fibrosis model in collaboration with Viskol
